Wardlume

Wardlume
A calm daily ritual app for iOS and Android offering guided reflection and AI conversations for personal well-being.
About
Pricing
View pricing page ↗
What does Wardlume do?
Wardlume is a mobile application for iOS and Android that provides users with a calm daily ritual for personal well-being. It features a morning check-in with a daily 'light' to carry and an evening moment for reflection and release, complemented by an AI for end-of-day conversations. The app aims to offer a warm practice for calm and reflection, distinct from medical or psychological treatment.
Is Wardlume trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Wardlume is 58 out of 100, based on site security posture and privacy practices.
When was Wardlume founded?
Wardlume was founded in 2026.
What industry does Wardlume operate in?
Wardlume operates in Consumer App, Mental Wellness, Meditation App, AI Chatbot, Personal Growth, Wellbeing.
Post an issue. The company answers.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
A platform for creating and interacting with sentient, semi-sapient AI characters for custom roleplays and conversations.
Cartender builds custom AI vehicle advisors for dealerships, translating shopper conversations into actionable insights.
AI-powered platform for personalized weight management and health coaching.
A generative AI chatbot service where users can create and converse with customizable AI characters.
An AI companion platform offering personalized, emotionally intelligent virtual interactions with customizable AI characters.
Guardian AI designs, builds, and deploys enterprise AI solutions, including AI agents, chatbots, and private AI platforms.
An entrant is a company tagged AI Chatbot whose domain was first registered in the window, counted from registry records in the StartupHub directory. 21 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
